Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
RXN > SEC Filings for RXN > Form 8-K on 15-Aug-2014All Recent SEC Filings

Show all filings for REXNORD CORP

Form 8-K for REXNORD CORP


15-Aug-2014

Entry into a Material Definitive Agreement, Financial Statements and Exhibits


Item 1.01 Entry into a Material Definitive Agreement

On August 11, 2014, Rexnord Corporation (the "Company") entered into an Underwriting Agreement (the "Underwriting Agreement") by and among the Company, certain funds affiliated with Apollo Global Management, LLC (collectively with its subsidiaries, "Apollo") and Deutsche Bank Securities Inc. (the "Underwriter"), for the sale of 10,000,000 shares of common stock, par value $0.01 per share, of the Company ("Common Stock") by Apollo. The offering was made under the Company's registration statement on Form S-3ASR (File No. 333-193610) filed with the Securities and Exchange Commission (the "Registration Statement"). The offering closed on August 15, 2014. Pursuant to the terms of the Underwriting Agreement, the Company and Apollo have agreed to indemnify the Underwriter against certain liabilities, including liabilities under the Securities Act of 1933, as amended, or to contribute to payments the Underwriter may be required to make because of any of those liabilities.

The Company did not sell any shares in the offering and did not receive any proceeds from the sale of shares of Common Stock by Apollo.

The Underwriter and its affiliates are full service financial institutions engaged in various activities, which may include securities trading, commercial and investment banking, financial advisory, investment management, investment research, principal investment, hedging, financing and brokerage activities. The Underwriter and certain of its affiliates have, from time to time, performed, and may in the future perform, various financial advisory and investment banking services for the Company, for which they received or will receive customary fees and expenses. The Underwriter and/or certain of its affiliates may have an indirect ownership interest in the Company through various private equity funds, including funds of Apollo and/or its affiliates. The Underwriter or certain of its affiliates are lenders under the Company's credit agreement.

In the ordinary course of their various business activities, the Underwriter and its affiliates may make or hold a broad array of investments and actively trade debt and equity securities (or related derivative securities) and financial instruments (including bank loans) for their own account and for the accounts of their customers, and such investment and securities activities may involve securities and/or instruments of the Company. The Underwriter and its affiliates may also make investment recommendations and/or publish or express independent research views in respect of such securities or instruments and may at any time hold, or recommend to clients that they acquire, long and/or short positions in such securities and instruments.

The summary set forth above is not intended to be complete and is qualified in its entirety by reference to the full text of the Underwriting Agreement, which is attached hereto as Exhibit 1.1 and incorporated by reference.



Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit
  No.                                     Description

  1.1        Underwriting Agreement, dated as of August 11, 2014, by and among
             Rexnord Corporation, Rexnord Acquisition Holdings I, LLC and Rexnord
             Acquisition Holdings II, LLC, as the selling stockholders, and
             Deutsche Bank Securities Inc.

  5.1        Opinion of Paul, Weiss, Rifkind, Wharton & Garrison, LLP

 23.1        Consent of Paul, Weiss, Rifkind, Wharton & Garrison, LLP (included in
             Exhibit 5.1)


  Add RXN to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for RXN - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.